Skip to content

Clinical trials

Phase 4 Hemophilia A trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 4 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20065
20091
20101
20172
20182
20201
20212
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Terminated4
Withdrawn3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baxalta now part of Shire3
Bayer3
Wyeth is now a wholly owned subsidiary of Pfizer3
Octapharma2
Sanofi2
American Thrombosis and Hemostasis Network1
CSL Behring1
Children's Hospital Los Angeles1
Fondazione Angelo Bianchi Bonomi1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A26
Hematologic Diseases2
Hemophilia B2
Hemostatic Disorders2
Blood Coagulation Disorders1
Blood Platelet Disorders1
HIV Infections1
von Willebrand Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.